WHO Executive Board Discusses COVID-19 Responses, Vaccine Allocation, U.S. Withdrawal

Devex: Vaccine allocation and WHO reform take center stage as WHO executive board meets
“During the two-day, semivirtual session of the World Health Organization executive board meeting this week, officials gave member states an overview of the COVID-19 response to date and provided updates on the changes that have taken place within the organization to support coronavirus response efforts. These changes include the creation of WHO’s science division — which initiated the Solidarity Trial to compare COVID-19 treatments and assess their effectiveness — and the new emergency preparedness division under the WHO Health Emergencies Program. Member states also asked questions on vaccine allocation and raised concerns about the planned U.S. withdrawal from the organization. Missing from the event, however, were the voices of civil society organizations, which expressed concern over their exclusion from the discussions…” (Ravelo, 10/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.